The e-licensing ceremony was graced by Dr. Renu Swarup, Secretary, DBT and dignitaries from ICAR, DAHD, BIRAC, BCIL and M/s Hester Biosciences Pvt. Ltd., Ahmedabad.
Padma Shri Prof. Ananda Mohan Chakrabarty, a renowned Indian microbiologist passed away on July 10, 2020 in USA. Prof. Chakrabarty is known for his great contribution in research on directed evolution and development of genetically engineered organisms, the famous oil-eating bacteria that led to the well known case Diamond v. Chakrabarty on patentability of microorganisms.
Dr. Purnima Sharma, MD BCIL briefing Hon'ble Prime Minister of India and the President of Kenya about BCIL Activities.
Dr. Purnima Sharma, MD BCIL Congratulates Dr. Renu Swarup for taking over as the Secretary Department of Biotechnology Government of India.
BCIL facilitated licensing of White Rust resistant Mustard technology, developed by Delhi University through DBT support to five companies Hytech Seed India Pvt Ltd, Hyderabad, Rasi Seeds (P), Ganga Kaveri Seeds Pvt Ltd., Metahelix Life Sciences Ltd., Tierra Agrotech Ltd. during 7th Foundation day celebrations of BIRAC on March 19th, 2019 in presence of Dr. Renu Swarup, Secretary DBT and Dr. Mohd. Aslam, MD, BIRAC.
Attention:-Bioinformatics Programs (BINC and BIITP)
1. Bioinformatics National Certification (BINC) has been merged with DBT-Junior Research Fellow (BET Exam)
2. Bioinformatics Industrial Training Program (BIITP) is merged with HRDBiotechnology Industrial Training Programme (BITP).
Notice Sub: Submission of pending UC, SOE and Claim form
Erythropoietin (EPO) is used in many clinical settings for anaemic patients. Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO as these diseases may cause anemia. A second-generation erythropoietin analogue, Darbepoetin alpha, was created aiming longer elimination half-life in vivo that translated into less frequent dosing, usually once weekly or once every 2 week.
Milk derived primary Mammary Epithelial Cells (pMECs) are potential tools in pursuit of future scientific breakthrough as they represent 90% of in-vivo environment as compared to transformed cells. Lack of commercial availability of pMECs is a problem faced by scientific community.